nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetaminophen—PTGS1—kidney cancer	0.121	0.336	CbGaD
Acetaminophen—CYP1A1—kidney cancer	0.111	0.308	CbGaD
Acetaminophen—PTGS2—kidney cancer	0.0691	0.192	CbGaD
Acetaminophen—ABCB1—kidney cancer	0.0587	0.164	CbGaD
Acetaminophen—UGT1A1—Pazopanib—kidney cancer	0.0411	0.111	CbGbCtD
Acetaminophen—UGT1A1—Erlotinib—kidney cancer	0.0293	0.0794	CbGbCtD
Acetaminophen—UGT1A9—Sorafenib—kidney cancer	0.0291	0.0789	CbGbCtD
Acetaminophen—UGT1A1—Sorafenib—kidney cancer	0.0238	0.0645	CbGbCtD
Acetaminophen—ABCB1—Temsirolimus—kidney cancer	0.0155	0.042	CbGbCtD
Acetaminophen—CYP1A1—Erlotinib—kidney cancer	0.0149	0.0403	CbGbCtD
Acetaminophen—CYP2D6—Temsirolimus—kidney cancer	0.0146	0.0396	CbGbCtD
Acetaminophen—CYP3A4—Everolimus—kidney cancer	0.0138	0.0372	CbGbCtD
Acetaminophen—CYP2C8—Pazopanib—kidney cancer	0.012	0.0326	CbGbCtD
Acetaminophen—CYP1A2—Pazopanib—kidney cancer	0.00931	0.0252	CbGbCtD
Acetaminophen—CYP3A4—Temsirolimus—kidney cancer	0.00929	0.0252	CbGbCtD
Acetaminophen—CYP2C9—Capecitabine—kidney cancer	0.00875	0.0237	CbGbCtD
Acetaminophen—NAT2—urine—kidney cancer	0.00861	0.183	CbGeAlD
Acetaminophen—CYP2C8—Erlotinib—kidney cancer	0.00859	0.0233	CbGbCtD
Acetaminophen—ABCB1—Pazopanib—kidney cancer	0.00814	0.0221	CbGbCtD
Acetaminophen—CYP2C8—Paclitaxel—kidney cancer	0.00786	0.0213	CbGbCtD
Acetaminophen—CYP2D6—Pazopanib—kidney cancer	0.00767	0.0208	CbGbCtD
Acetaminophen—ABCB1—Dactinomycin—kidney cancer	0.00745	0.0202	CbGbCtD
Acetaminophen—CYP2C8—Sorafenib—kidney cancer	0.00698	0.0189	CbGbCtD
Acetaminophen—CYP1A2—Erlotinib—kidney cancer	0.00665	0.018	CbGbCtD
Acetaminophen—ABCB1—Gemcitabine—kidney cancer	0.00589	0.0159	CbGbCtD
Acetaminophen—ABCB1—Erlotinib—kidney cancer	0.00581	0.0157	CbGbCtD
Acetaminophen—CYP2C9—Paclitaxel—kidney cancer	0.00548	0.0148	CbGbCtD
Acetaminophen—CYP2D6—Erlotinib—kidney cancer	0.00548	0.0148	CbGbCtD
Acetaminophen—CYP1A2—Sorafenib—kidney cancer	0.0054	0.0146	CbGbCtD
Acetaminophen—ABCB1—Paclitaxel—kidney cancer	0.00532	0.0144	CbGbCtD
Acetaminophen—CYP3A4—Pazopanib—kidney cancer	0.00488	0.0132	CbGbCtD
Acetaminophen—CYP2C9—Sorafenib—kidney cancer	0.00487	0.0132	CbGbCtD
Acetaminophen—ABCB1—Sorafenib—kidney cancer	0.00473	0.0128	CbGbCtD
Acetaminophen—ABCB1—Vinblastine—kidney cancer	0.00467	0.0126	CbGbCtD
Acetaminophen—ABCB1—Vincristine—kidney cancer	0.00459	0.0124	CbGbCtD
Acetaminophen—CYP2D6—Sorafenib—kidney cancer	0.00445	0.0121	CbGbCtD
Acetaminophen—CYP2D6—Vinblastine—kidney cancer	0.0044	0.0119	CbGbCtD
Acetaminophen—ABCB1—Sunitinib—kidney cancer	0.00383	0.0104	CbGbCtD
Acetaminophen—CYP3A4—Erlotinib—kidney cancer	0.00348	0.00943	CbGbCtD
Acetaminophen—UGT1A1—urine—kidney cancer	0.00319	0.0679	CbGeAlD
Acetaminophen—CYP3A4—Paclitaxel—kidney cancer	0.00319	0.00863	CbGbCtD
Acetaminophen—ABCB1—Doxorubicin—kidney cancer	0.00287	0.00776	CbGbCtD
Acetaminophen—CYP3A4—Sorafenib—kidney cancer	0.00283	0.00767	CbGbCtD
Acetaminophen—CYP3A4—Vinblastine—kidney cancer	0.0028	0.00757	CbGbCtD
Acetaminophen—CYP3A4—Vincristine—kidney cancer	0.00275	0.00744	CbGbCtD
Acetaminophen—CYP2D6—Doxorubicin—kidney cancer	0.0027	0.00732	CbGbCtD
Acetaminophen—CYP3A4—Sunitinib—kidney cancer	0.00229	0.00621	CbGbCtD
Acetaminophen—UGT1A10—renal system—kidney cancer	0.00227	0.0483	CbGeAlD
Acetaminophen—UGT1A10—kidney—kidney cancer	0.00219	0.0467	CbGeAlD
Acetaminophen—NAT2—renal system—kidney cancer	0.00211	0.0449	CbGeAlD
Acetaminophen—SULT2A1—gonad—kidney cancer	0.00176	0.0374	CbGeAlD
Acetaminophen—CYP3A4—Doxorubicin—kidney cancer	0.00172	0.00465	CbGbCtD
Acetaminophen—SULT1E1—gonad—kidney cancer	0.00162	0.0345	CbGeAlD
Acetaminophen—SULT1A1—renal system—kidney cancer	0.00156	0.0331	CbGeAlD
Acetaminophen—SULT1A1—kidney—kidney cancer	0.0015	0.032	CbGeAlD
Acetaminophen—PTGS2—nephron—kidney cancer	0.00146	0.031	CbGeAlD
Acetaminophen—CYP1A2—urine—kidney cancer	0.00141	0.0301	CbGeAlD
Acetaminophen—TRPV1—renal system—kidney cancer	0.00137	0.0292	CbGeAlD
Acetaminophen—CYP2C9—urine—kidney cancer	0.00134	0.0285	CbGeAlD
Acetaminophen—CYP2E1—urine—kidney cancer	0.00127	0.027	CbGeAlD
Acetaminophen—TRPV1—gonad—kidney cancer	0.00123	0.0262	CbGeAlD
Acetaminophen—UGT1A9—renal system—kidney cancer	0.00114	0.0242	CbGeAlD
Acetaminophen—UGT1A9—kidney—kidney cancer	0.0011	0.0234	CbGeAlD
Acetaminophen—CYP3A4—urine—kidney cancer	0.00102	0.0218	CbGeAlD
Acetaminophen—CYP2D6—urine—kidney cancer	0.00101	0.0214	CbGeAlD
Acetaminophen—SLC22A6—nephron tubule—kidney cancer	0.000927	0.0197	CbGeAlD
Acetaminophen—SLC22A6—cortex of kidney—kidney cancer	0.000793	0.0169	CbGeAlD
Acetaminophen—UGT1A1—renal system—kidney cancer	0.00078	0.0166	CbGeAlD
Acetaminophen—UGT1A1—kidney—kidney cancer	0.000754	0.0161	CbGeAlD
Acetaminophen—CYP2C8—renal system—kidney cancer	0.000369	0.00786	CbGeAlD
Acetaminophen—CYP2C8—kidney—kidney cancer	0.000357	0.0076	CbGeAlD
Acetaminophen—CYP1A2—renal system—kidney cancer	0.000345	0.00735	CbGeAlD
Acetaminophen—CYP2E1—nephron tubule—kidney cancer	0.000342	0.00728	CbGeAlD
Acetaminophen—CYP1A1—renal system—kidney cancer	0.000341	0.00725	CbGeAlD
Acetaminophen—CYP1A1—kidney—kidney cancer	0.000329	0.00701	CbGeAlD
Acetaminophen—CYP2E1—renal system—kidney cancer	0.000311	0.00662	CbGeAlD
Acetaminophen—CYP1A1—cardiac atrium—kidney cancer	0.000305	0.0065	CbGeAlD
Acetaminophen—CYP2E1—kidney—kidney cancer	0.0003	0.0064	CbGeAlD
Acetaminophen—PTGS1—renal system—kidney cancer	0.000299	0.00637	CbGeAlD
Acetaminophen—CYP2E1—cortex of kidney—kidney cancer	0.000293	0.00623	CbGeAlD
Acetaminophen—PTGS1—kidney—kidney cancer	0.000289	0.00616	CbGeAlD
Acetaminophen—PTGS2—renal system—kidney cancer	0.000286	0.00609	CbGeAlD
Acetaminophen—PTGS2—kidney—kidney cancer	0.000277	0.00589	CbGeAlD
Acetaminophen—PTGS1—cardiac atrium—kidney cancer	0.000268	0.00571	CbGeAlD
Acetaminophen—CYP3A4—renal system—kidney cancer	0.00025	0.00532	CbGeAlD
Acetaminophen—CYP2D6—renal system—kidney cancer	0.000246	0.00524	CbGeAlD
Acetaminophen—CYP3A4—kidney—kidney cancer	0.000242	0.00515	CbGeAlD
Acetaminophen—CYP2D6—kidney—kidney cancer	0.000238	0.00506	CbGeAlD
Acetaminophen—ABCB1—nephron tubule—kidney cancer	0.000195	0.00415	CbGeAlD
Acetaminophen—ABCB1—renal system—kidney cancer	0.000177	0.00377	CbGeAlD
Acetaminophen—ABCB1—kidney—kidney cancer	0.000171	0.00364	CbGeAlD
Acetaminophen—ABCB1—cortex of kidney—kidney cancer	0.000167	0.00355	CbGeAlD
Acetaminophen—ABCB1—gonad—kidney cancer	0.000159	0.00338	CbGeAlD
Acetaminophen—Pruritus—Sorafenib—kidney cancer	7.3e-05	0.00053	CcSEcCtD
Acetaminophen—Vomiting—Erlotinib—kidney cancer	7.29e-05	0.000529	CcSEcCtD
Acetaminophen—Erythema multiforme—Capecitabine—kidney cancer	7.28e-05	0.000529	CcSEcCtD
Acetaminophen—Gastrointestinal disorder—Vincristine—kidney cancer	7.25e-05	0.000526	CcSEcCtD
Acetaminophen—Fatigue—Vincristine—kidney cancer	7.24e-05	0.000526	CcSEcCtD
Acetaminophen—Rash—Erlotinib—kidney cancer	7.23e-05	0.000525	CcSEcCtD
Acetaminophen—Dermatitis—Erlotinib—kidney cancer	7.22e-05	0.000525	CcSEcCtD
Acetaminophen—Palpitations—Paclitaxel—kidney cancer	7.22e-05	0.000524	CcSEcCtD
Acetaminophen—Insomnia—Gemcitabine—kidney cancer	7.2e-05	0.000523	CcSEcCtD
Acetaminophen—Eye disorder—Capecitabine—kidney cancer	7.2e-05	0.000523	CcSEcCtD
Acetaminophen—Headache—Erlotinib—kidney cancer	7.18e-05	0.000522	CcSEcCtD
Acetaminophen—Constipation—Vincristine—kidney cancer	7.18e-05	0.000521	CcSEcCtD
Acetaminophen—Pain in extremity—Doxorubicin—kidney cancer	7.18e-05	0.000521	CcSEcCtD
Acetaminophen—Cardiac disorder—Capecitabine—kidney cancer	7.15e-05	0.000519	CcSEcCtD
Acetaminophen—Flushing—Capecitabine—kidney cancer	7.15e-05	0.000519	CcSEcCtD
Acetaminophen—Cough—Paclitaxel—kidney cancer	7.13e-05	0.000518	CcSEcCtD
Acetaminophen—Asthenia—Sunitinib—kidney cancer	7.12e-05	0.000517	CcSEcCtD
Acetaminophen—Dyspnoea—Gemcitabine—kidney cancer	7.1e-05	0.000516	CcSEcCtD
Acetaminophen—Nausea—Vinblastine—kidney cancer	7.09e-05	0.000515	CcSEcCtD
Acetaminophen—Somnolence—Gemcitabine—kidney cancer	7.08e-05	0.000514	CcSEcCtD
Acetaminophen—Convulsion—Paclitaxel—kidney cancer	7.08e-05	0.000514	CcSEcCtD
Acetaminophen—Nausea—Everolimus—kidney cancer	7.06e-05	0.000513	CcSEcCtD
Acetaminophen—Diarrhoea—Sorafenib—kidney cancer	7.06e-05	0.000513	CcSEcCtD
Acetaminophen—Hypertension—Paclitaxel—kidney cancer	7.05e-05	0.000512	CcSEcCtD
Acetaminophen—Pruritus—Sunitinib—kidney cancer	7.02e-05	0.00051	CcSEcCtD
Acetaminophen—Angiopathy—Capecitabine—kidney cancer	6.99e-05	0.000508	CcSEcCtD
Acetaminophen—Immune system disorder—Capecitabine—kidney cancer	6.96e-05	0.000505	CcSEcCtD
Acetaminophen—Chest pain—Paclitaxel—kidney cancer	6.96e-05	0.000505	CcSEcCtD
Acetaminophen—Mediastinal disorder—Capecitabine—kidney cancer	6.94e-05	0.000504	CcSEcCtD
Acetaminophen—Anxiety—Paclitaxel—kidney cancer	6.93e-05	0.000503	CcSEcCtD
Acetaminophen—Decreased appetite—Gemcitabine—kidney cancer	6.92e-05	0.000503	CcSEcCtD
Acetaminophen—Hypersensitivity—Dactinomycin—kidney cancer	6.92e-05	0.000503	CcSEcCtD
Acetaminophen—Chills—Capecitabine—kidney cancer	6.91e-05	0.000502	CcSEcCtD
Acetaminophen—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	6.91e-05	0.000502	CcSEcCtD
Acetaminophen—Gastrointestinal disorder—Gemcitabine—kidney cancer	6.88e-05	0.000499	CcSEcCtD
Acetaminophen—Discomfort—Paclitaxel—kidney cancer	6.87e-05	0.000499	CcSEcCtD
Acetaminophen—Fatigue—Gemcitabine—kidney cancer	6.87e-05	0.000499	CcSEcCtD
Acetaminophen—Gastrointestinal pain—Vincristine—kidney cancer	6.86e-05	0.000499	CcSEcCtD
Acetaminophen—Dizziness—Sorafenib—kidney cancer	6.82e-05	0.000495	CcSEcCtD
Acetaminophen—Constipation—Gemcitabine—kidney cancer	6.81e-05	0.000495	CcSEcCtD
Acetaminophen—Nausea—Erlotinib—kidney cancer	6.81e-05	0.000495	CcSEcCtD
Acetaminophen—Dry mouth—Paclitaxel—kidney cancer	6.8e-05	0.000494	CcSEcCtD
Acetaminophen—Diarrhoea—Sunitinib—kidney cancer	6.79e-05	0.000493	CcSEcCtD
Acetaminophen—Mental disorder—Capecitabine—kidney cancer	6.75e-05	0.00049	CcSEcCtD
Acetaminophen—Asthenia—Dactinomycin—kidney cancer	6.74e-05	0.00049	CcSEcCtD
Acetaminophen—Confusional state—Paclitaxel—kidney cancer	6.72e-05	0.000488	CcSEcCtD
Acetaminophen—Malnutrition—Capecitabine—kidney cancer	6.7e-05	0.000487	CcSEcCtD
Acetaminophen—Erythema—Capecitabine—kidney cancer	6.7e-05	0.000487	CcSEcCtD
Acetaminophen—Oedema—Paclitaxel—kidney cancer	6.67e-05	0.000484	CcSEcCtD
Acetaminophen—Anaphylactic shock—Paclitaxel—kidney cancer	6.67e-05	0.000484	CcSEcCtD
Acetaminophen—Body temperature increased—Vincristine—kidney cancer	6.64e-05	0.000482	CcSEcCtD
Acetaminophen—Abdominal pain—Vincristine—kidney cancer	6.64e-05	0.000482	CcSEcCtD
Acetaminophen—Dizziness—Sunitinib—kidney cancer	6.56e-05	0.000477	CcSEcCtD
Acetaminophen—Feeling abnormal—Gemcitabine—kidney cancer	6.56e-05	0.000477	CcSEcCtD
Acetaminophen—Shock—Paclitaxel—kidney cancer	6.56e-05	0.000476	CcSEcCtD
Acetaminophen—Vomiting—Sorafenib—kidney cancer	6.56e-05	0.000476	CcSEcCtD
Acetaminophen—Nervous system disorder—Paclitaxel—kidney cancer	6.54e-05	0.000475	CcSEcCtD
Acetaminophen—Hypokalaemia—Doxorubicin—kidney cancer	6.53e-05	0.000474	CcSEcCtD
Acetaminophen—Thrombocytopenia—Paclitaxel—kidney cancer	6.53e-05	0.000474	CcSEcCtD
Acetaminophen—Tachycardia—Paclitaxel—kidney cancer	6.51e-05	0.000473	CcSEcCtD
Acetaminophen—Rash—Sorafenib—kidney cancer	6.5e-05	0.000472	CcSEcCtD
Acetaminophen—Dermatitis—Sorafenib—kidney cancer	6.5e-05	0.000472	CcSEcCtD
Acetaminophen—Skin disorder—Paclitaxel—kidney cancer	6.48e-05	0.00047	CcSEcCtD
Acetaminophen—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	6.46e-05	0.000469	CcSEcCtD
Acetaminophen—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	6.46e-05	0.000469	CcSEcCtD
Acetaminophen—Headache—Sorafenib—kidney cancer	6.46e-05	0.000469	CcSEcCtD
Acetaminophen—Muscle spasms—Capecitabine—kidney cancer	6.45e-05	0.000468	CcSEcCtD
Acetaminophen—Hyperhidrosis—Paclitaxel—kidney cancer	6.45e-05	0.000468	CcSEcCtD
Acetaminophen—Diarrhoea—Dactinomycin—kidney cancer	6.43e-05	0.000467	CcSEcCtD
Acetaminophen—Anorexia—Paclitaxel—kidney cancer	6.36e-05	0.000462	CcSEcCtD
Acetaminophen—Muscular weakness—Doxorubicin—kidney cancer	6.33e-05	0.00046	CcSEcCtD
Acetaminophen—Vision blurred—Capecitabine—kidney cancer	6.32e-05	0.000459	CcSEcCtD
Acetaminophen—Vomiting—Sunitinib—kidney cancer	6.31e-05	0.000458	CcSEcCtD
Acetaminophen—Body temperature increased—Gemcitabine—kidney cancer	6.3e-05	0.000457	CcSEcCtD
Acetaminophen—Tremor—Capecitabine—kidney cancer	6.28e-05	0.000456	CcSEcCtD
Acetaminophen—Rash—Sunitinib—kidney cancer	6.26e-05	0.000455	CcSEcCtD
Acetaminophen—Dermatitis—Sunitinib—kidney cancer	6.25e-05	0.000454	CcSEcCtD
Acetaminophen—Abdominal distension—Doxorubicin—kidney cancer	6.24e-05	0.000454	CcSEcCtD
Acetaminophen—Hypotension—Paclitaxel—kidney cancer	6.23e-05	0.000453	CcSEcCtD
Acetaminophen—Ill-defined disorder—Capecitabine—kidney cancer	6.22e-05	0.000452	CcSEcCtD
Acetaminophen—Headache—Sunitinib—kidney cancer	6.22e-05	0.000452	CcSEcCtD
Acetaminophen—Asthma—Doxorubicin—kidney cancer	6.2e-05	0.00045	CcSEcCtD
Acetaminophen—Anaemia—Capecitabine—kidney cancer	6.2e-05	0.00045	CcSEcCtD
Acetaminophen—Hypersensitivity—Vincristine—kidney cancer	6.18e-05	0.000449	CcSEcCtD
Acetaminophen—Nausea—Sorafenib—kidney cancer	6.13e-05	0.000445	CcSEcCtD
Acetaminophen—Malaise—Capecitabine—kidney cancer	6.05e-05	0.000439	CcSEcCtD
Acetaminophen—Insomnia—Paclitaxel—kidney cancer	6.03e-05	0.000438	CcSEcCtD
Acetaminophen—Asthenia—Vincristine—kidney cancer	6.02e-05	0.000437	CcSEcCtD
Acetaminophen—Leukopenia—Capecitabine—kidney cancer	6e-05	0.000436	CcSEcCtD
Acetaminophen—Vomiting—Dactinomycin—kidney cancer	5.97e-05	0.000434	CcSEcCtD
Acetaminophen—Dyspnoea—Paclitaxel—kidney cancer	5.94e-05	0.000432	CcSEcCtD
Acetaminophen—Somnolence—Paclitaxel—kidney cancer	5.93e-05	0.000431	CcSEcCtD
Acetaminophen—Palpitations—Capecitabine—kidney cancer	5.92e-05	0.00043	CcSEcCtD
Acetaminophen—Rash—Dactinomycin—kidney cancer	5.92e-05	0.00043	CcSEcCtD
Acetaminophen—Nausea—Sunitinib—kidney cancer	5.9e-05	0.000428	CcSEcCtD
Acetaminophen—Pancytopenia—Doxorubicin—kidney cancer	5.89e-05	0.000428	CcSEcCtD
Acetaminophen—Dyspepsia—Paclitaxel—kidney cancer	5.87e-05	0.000426	CcSEcCtD
Acetaminophen—Cough—Capecitabine—kidney cancer	5.85e-05	0.000425	CcSEcCtD
Acetaminophen—Dysuria—Doxorubicin—kidney cancer	5.8e-05	0.000421	CcSEcCtD
Acetaminophen—Neutropenia—Doxorubicin—kidney cancer	5.8e-05	0.000421	CcSEcCtD
Acetaminophen—Decreased appetite—Paclitaxel—kidney cancer	5.8e-05	0.000421	CcSEcCtD
Acetaminophen—Hypertension—Capecitabine—kidney cancer	5.79e-05	0.00042	CcSEcCtD
Acetaminophen—Gastrointestinal disorder—Paclitaxel—kidney cancer	5.76e-05	0.000418	CcSEcCtD
Acetaminophen—Fatigue—Paclitaxel—kidney cancer	5.75e-05	0.000418	CcSEcCtD
Acetaminophen—Diarrhoea—Vincristine—kidney cancer	5.74e-05	0.000417	CcSEcCtD
Acetaminophen—Asthenia—Gemcitabine—kidney cancer	5.71e-05	0.000415	CcSEcCtD
Acetaminophen—Chest pain—Capecitabine—kidney cancer	5.71e-05	0.000415	CcSEcCtD
Acetaminophen—Constipation—Paclitaxel—kidney cancer	5.7e-05	0.000414	CcSEcCtD
Acetaminophen—Anxiety—Capecitabine—kidney cancer	5.69e-05	0.000413	CcSEcCtD
Acetaminophen—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	5.67e-05	0.000412	CcSEcCtD
Acetaminophen—Photosensitivity reaction—Doxorubicin—kidney cancer	5.66e-05	0.000411	CcSEcCtD
Acetaminophen—Discomfort—Capecitabine—kidney cancer	5.64e-05	0.00041	CcSEcCtD
Acetaminophen—Pruritus—Gemcitabine—kidney cancer	5.63e-05	0.000409	CcSEcCtD
Acetaminophen—Hyperglycaemia—Doxorubicin—kidney cancer	5.59e-05	0.000406	CcSEcCtD
Acetaminophen—Dry mouth—Capecitabine—kidney cancer	5.58e-05	0.000405	CcSEcCtD
Acetaminophen—Nausea—Dactinomycin—kidney cancer	5.58e-05	0.000405	CcSEcCtD
Acetaminophen—Dizziness—Vincristine—kidney cancer	5.55e-05	0.000403	CcSEcCtD
Acetaminophen—Drowsiness—Doxorubicin—kidney cancer	5.53e-05	0.000402	CcSEcCtD
Acetaminophen—Confusional state—Capecitabine—kidney cancer	5.52e-05	0.000401	CcSEcCtD
Acetaminophen—Feeling abnormal—Paclitaxel—kidney cancer	5.49e-05	0.000399	CcSEcCtD
Acetaminophen—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	5.48e-05	0.000398	CcSEcCtD
Acetaminophen—Oedema—Capecitabine—kidney cancer	5.47e-05	0.000397	CcSEcCtD
Acetaminophen—Gastrointestinal pain—Paclitaxel—kidney cancer	5.45e-05	0.000396	CcSEcCtD
Acetaminophen—Diarrhoea—Gemcitabine—kidney cancer	5.45e-05	0.000396	CcSEcCtD
Acetaminophen—Shock—Capecitabine—kidney cancer	5.38e-05	0.000391	CcSEcCtD
Acetaminophen—Nervous system disorder—Capecitabine—kidney cancer	5.37e-05	0.00039	CcSEcCtD
Acetaminophen—Thrombocytopenia—Capecitabine—kidney cancer	5.36e-05	0.000389	CcSEcCtD
Acetaminophen—Tachycardia—Capecitabine—kidney cancer	5.34e-05	0.000388	CcSEcCtD
Acetaminophen—Vomiting—Vincristine—kidney cancer	5.34e-05	0.000388	CcSEcCtD
Acetaminophen—Skin disorder—Capecitabine—kidney cancer	5.31e-05	0.000386	CcSEcCtD
Acetaminophen—Sweating—Doxorubicin—kidney cancer	5.3e-05	0.000385	CcSEcCtD
Acetaminophen—Urticaria—Paclitaxel—kidney cancer	5.3e-05	0.000385	CcSEcCtD
Acetaminophen—Rash—Vincristine—kidney cancer	5.29e-05	0.000384	CcSEcCtD
Acetaminophen—Hyperhidrosis—Capecitabine—kidney cancer	5.29e-05	0.000384	CcSEcCtD
Acetaminophen—Dermatitis—Vincristine—kidney cancer	5.29e-05	0.000384	CcSEcCtD
Acetaminophen—Abdominal pain—Paclitaxel—kidney cancer	5.27e-05	0.000383	CcSEcCtD
Acetaminophen—Body temperature increased—Paclitaxel—kidney cancer	5.27e-05	0.000383	CcSEcCtD
Acetaminophen—Headache—Vincristine—kidney cancer	5.26e-05	0.000382	CcSEcCtD
Acetaminophen—Hepatobiliary disease—Doxorubicin—kidney cancer	5.23e-05	0.00038	CcSEcCtD
Acetaminophen—Anorexia—Capecitabine—kidney cancer	5.22e-05	0.000379	CcSEcCtD
Acetaminophen—Agranulocytosis—Doxorubicin—kidney cancer	5.16e-05	0.000375	CcSEcCtD
Acetaminophen—Hypotension—Capecitabine—kidney cancer	5.11e-05	0.000371	CcSEcCtD
Acetaminophen—Vomiting—Gemcitabine—kidney cancer	5.06e-05	0.000368	CcSEcCtD
Acetaminophen—Rash—Gemcitabine—kidney cancer	5.02e-05	0.000365	CcSEcCtD
Acetaminophen—Dermatitis—Gemcitabine—kidney cancer	5.02e-05	0.000364	CcSEcCtD
Acetaminophen—Haemoglobin—Doxorubicin—kidney cancer	4.99e-05	0.000362	CcSEcCtD
Acetaminophen—Headache—Gemcitabine—kidney cancer	4.99e-05	0.000362	CcSEcCtD
Acetaminophen—Nausea—Vincristine—kidney cancer	4.99e-05	0.000362	CcSEcCtD
Acetaminophen—Haemorrhage—Doxorubicin—kidney cancer	4.96e-05	0.000361	CcSEcCtD
Acetaminophen—Hepatitis—Doxorubicin—kidney cancer	4.96e-05	0.000361	CcSEcCtD
Acetaminophen—Insomnia—Capecitabine—kidney cancer	4.95e-05	0.000359	CcSEcCtD
Acetaminophen—Hypersensitivity—Paclitaxel—kidney cancer	4.91e-05	0.000357	CcSEcCtD
Acetaminophen—Urinary tract disorder—Doxorubicin—kidney cancer	4.9e-05	0.000356	CcSEcCtD
Acetaminophen—Oedema peripheral—Doxorubicin—kidney cancer	4.89e-05	0.000355	CcSEcCtD
Acetaminophen—Connective tissue disorder—Doxorubicin—kidney cancer	4.88e-05	0.000354	CcSEcCtD
Acetaminophen—Dyspnoea—Capecitabine—kidney cancer	4.88e-05	0.000354	CcSEcCtD
Acetaminophen—Urethral disorder—Doxorubicin—kidney cancer	4.87e-05	0.000353	CcSEcCtD
Acetaminophen—Dyspepsia—Capecitabine—kidney cancer	4.82e-05	0.00035	CcSEcCtD
Acetaminophen—Asthenia—Paclitaxel—kidney cancer	4.78e-05	0.000347	CcSEcCtD
Acetaminophen—Decreased appetite—Capecitabine—kidney cancer	4.76e-05	0.000345	CcSEcCtD
Acetaminophen—Nausea—Gemcitabine—kidney cancer	4.73e-05	0.000344	CcSEcCtD
Acetaminophen—Gastrointestinal disorder—Capecitabine—kidney cancer	4.72e-05	0.000343	CcSEcCtD
Acetaminophen—Fatigue—Capecitabine—kidney cancer	4.72e-05	0.000343	CcSEcCtD
Acetaminophen—Pruritus—Paclitaxel—kidney cancer	4.72e-05	0.000343	CcSEcCtD
Acetaminophen—Erythema multiforme—Doxorubicin—kidney cancer	4.69e-05	0.000341	CcSEcCtD
Acetaminophen—Constipation—Capecitabine—kidney cancer	4.68e-05	0.00034	CcSEcCtD
Acetaminophen—Eye disorder—Doxorubicin—kidney cancer	4.64e-05	0.000337	CcSEcCtD
Acetaminophen—Flushing—Doxorubicin—kidney cancer	4.61e-05	0.000335	CcSEcCtD
Acetaminophen—Cardiac disorder—Doxorubicin—kidney cancer	4.61e-05	0.000335	CcSEcCtD
Acetaminophen—Diarrhoea—Paclitaxel—kidney cancer	4.56e-05	0.000331	CcSEcCtD
Acetaminophen—Feeling abnormal—Capecitabine—kidney cancer	4.51e-05	0.000327	CcSEcCtD
Acetaminophen—Angiopathy—Doxorubicin—kidney cancer	4.5e-05	0.000327	CcSEcCtD
Acetaminophen—Immune system disorder—Doxorubicin—kidney cancer	4.48e-05	0.000326	CcSEcCtD
Acetaminophen—Gastrointestinal pain—Capecitabine—kidney cancer	4.47e-05	0.000325	CcSEcCtD
Acetaminophen—Mediastinal disorder—Doxorubicin—kidney cancer	4.47e-05	0.000325	CcSEcCtD
Acetaminophen—Chills—Doxorubicin—kidney cancer	4.45e-05	0.000324	CcSEcCtD
Acetaminophen—Dizziness—Paclitaxel—kidney cancer	4.41e-05	0.00032	CcSEcCtD
Acetaminophen—Mental disorder—Doxorubicin—kidney cancer	4.35e-05	0.000316	CcSEcCtD
Acetaminophen—Urticaria—Capecitabine—kidney cancer	4.35e-05	0.000316	CcSEcCtD
Acetaminophen—Body temperature increased—Capecitabine—kidney cancer	4.33e-05	0.000314	CcSEcCtD
Acetaminophen—Abdominal pain—Capecitabine—kidney cancer	4.33e-05	0.000314	CcSEcCtD
Acetaminophen—Malnutrition—Doxorubicin—kidney cancer	4.32e-05	0.000314	CcSEcCtD
Acetaminophen—Erythema—Doxorubicin—kidney cancer	4.32e-05	0.000314	CcSEcCtD
Acetaminophen—Tension—Doxorubicin—kidney cancer	4.24e-05	0.000308	CcSEcCtD
Acetaminophen—Vomiting—Paclitaxel—kidney cancer	4.24e-05	0.000308	CcSEcCtD
Acetaminophen—Rash—Paclitaxel—kidney cancer	4.2e-05	0.000305	CcSEcCtD
Acetaminophen—Dermatitis—Paclitaxel—kidney cancer	4.2e-05	0.000305	CcSEcCtD
Acetaminophen—Nervousness—Doxorubicin—kidney cancer	4.2e-05	0.000305	CcSEcCtD
Acetaminophen—Headache—Paclitaxel—kidney cancer	4.18e-05	0.000303	CcSEcCtD
Acetaminophen—Muscle spasms—Doxorubicin—kidney cancer	4.15e-05	0.000302	CcSEcCtD
Acetaminophen—Vision blurred—Doxorubicin—kidney cancer	4.07e-05	0.000296	CcSEcCtD
Acetaminophen—Hypersensitivity—Capecitabine—kidney cancer	4.03e-05	0.000293	CcSEcCtD
Acetaminophen—Ill-defined disorder—Doxorubicin—kidney cancer	4.01e-05	0.000291	CcSEcCtD
Acetaminophen—Anaemia—Doxorubicin—kidney cancer	3.99e-05	0.00029	CcSEcCtD
Acetaminophen—Agitation—Doxorubicin—kidney cancer	3.97e-05	0.000288	CcSEcCtD
Acetaminophen—Nausea—Paclitaxel—kidney cancer	3.96e-05	0.000288	CcSEcCtD
Acetaminophen—Asthenia—Capecitabine—kidney cancer	3.93e-05	0.000285	CcSEcCtD
Acetaminophen—Malaise—Doxorubicin—kidney cancer	3.9e-05	0.000283	CcSEcCtD
Acetaminophen—Pruritus—Capecitabine—kidney cancer	3.87e-05	0.000281	CcSEcCtD
Acetaminophen—Leukopenia—Doxorubicin—kidney cancer	3.87e-05	0.000281	CcSEcCtD
Acetaminophen—Palpitations—Doxorubicin—kidney cancer	3.82e-05	0.000277	CcSEcCtD
Acetaminophen—Cough—Doxorubicin—kidney cancer	3.77e-05	0.000274	CcSEcCtD
Acetaminophen—Convulsion—Doxorubicin—kidney cancer	3.74e-05	0.000272	CcSEcCtD
Acetaminophen—Diarrhoea—Capecitabine—kidney cancer	3.74e-05	0.000272	CcSEcCtD
Acetaminophen—Hypertension—Doxorubicin—kidney cancer	3.73e-05	0.000271	CcSEcCtD
Acetaminophen—Chest pain—Doxorubicin—kidney cancer	3.68e-05	0.000267	CcSEcCtD
Acetaminophen—Anxiety—Doxorubicin—kidney cancer	3.67e-05	0.000266	CcSEcCtD
Acetaminophen—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	3.65e-05	0.000265	CcSEcCtD
Acetaminophen—Discomfort—Doxorubicin—kidney cancer	3.64e-05	0.000264	CcSEcCtD
Acetaminophen—Dizziness—Capecitabine—kidney cancer	3.62e-05	0.000263	CcSEcCtD
Acetaminophen—Dry mouth—Doxorubicin—kidney cancer	3.6e-05	0.000261	CcSEcCtD
Acetaminophen—Confusional state—Doxorubicin—kidney cancer	3.56e-05	0.000258	CcSEcCtD
Acetaminophen—Anaphylactic shock—Doxorubicin—kidney cancer	3.53e-05	0.000256	CcSEcCtD
Acetaminophen—Oedema—Doxorubicin—kidney cancer	3.53e-05	0.000256	CcSEcCtD
Acetaminophen—Vomiting—Capecitabine—kidney cancer	3.48e-05	0.000253	CcSEcCtD
Acetaminophen—Shock—Doxorubicin—kidney cancer	3.47e-05	0.000252	CcSEcCtD
Acetaminophen—Nervous system disorder—Doxorubicin—kidney cancer	3.46e-05	0.000251	CcSEcCtD
Acetaminophen—Thrombocytopenia—Doxorubicin—kidney cancer	3.45e-05	0.000251	CcSEcCtD
Acetaminophen—Rash—Capecitabine—kidney cancer	3.45e-05	0.000251	CcSEcCtD
Acetaminophen—Dermatitis—Capecitabine—kidney cancer	3.45e-05	0.00025	CcSEcCtD
Acetaminophen—Tachycardia—Doxorubicin—kidney cancer	3.44e-05	0.00025	CcSEcCtD
Acetaminophen—Headache—Capecitabine—kidney cancer	3.43e-05	0.000249	CcSEcCtD
Acetaminophen—Skin disorder—Doxorubicin—kidney cancer	3.43e-05	0.000249	CcSEcCtD
Acetaminophen—Hyperhidrosis—Doxorubicin—kidney cancer	3.41e-05	0.000248	CcSEcCtD
Acetaminophen—Anorexia—Doxorubicin—kidney cancer	3.36e-05	0.000244	CcSEcCtD
Acetaminophen—Hypotension—Doxorubicin—kidney cancer	3.3e-05	0.000239	CcSEcCtD
Acetaminophen—Nausea—Capecitabine—kidney cancer	3.25e-05	0.000236	CcSEcCtD
Acetaminophen—Insomnia—Doxorubicin—kidney cancer	3.19e-05	0.000232	CcSEcCtD
Acetaminophen—Dyspnoea—Doxorubicin—kidney cancer	3.14e-05	0.000228	CcSEcCtD
Acetaminophen—Somnolence—Doxorubicin—kidney cancer	3.14e-05	0.000228	CcSEcCtD
Acetaminophen—Dyspepsia—Doxorubicin—kidney cancer	3.1e-05	0.000226	CcSEcCtD
Acetaminophen—Decreased appetite—Doxorubicin—kidney cancer	3.07e-05	0.000223	CcSEcCtD
Acetaminophen—Gastrointestinal disorder—Doxorubicin—kidney cancer	3.04e-05	0.000221	CcSEcCtD
Acetaminophen—Fatigue—Doxorubicin—kidney cancer	3.04e-05	0.000221	CcSEcCtD
Acetaminophen—Constipation—Doxorubicin—kidney cancer	3.02e-05	0.000219	CcSEcCtD
Acetaminophen—Feeling abnormal—Doxorubicin—kidney cancer	2.91e-05	0.000211	CcSEcCtD
Acetaminophen—Gastrointestinal pain—Doxorubicin—kidney cancer	2.88e-05	0.000209	CcSEcCtD
Acetaminophen—Urticaria—Doxorubicin—kidney cancer	2.8e-05	0.000204	CcSEcCtD
Acetaminophen—Abdominal pain—Doxorubicin—kidney cancer	2.79e-05	0.000203	CcSEcCtD
Acetaminophen—Body temperature increased—Doxorubicin—kidney cancer	2.79e-05	0.000203	CcSEcCtD
Acetaminophen—Hypersensitivity—Doxorubicin—kidney cancer	2.6e-05	0.000189	CcSEcCtD
Acetaminophen—Asthenia—Doxorubicin—kidney cancer	2.53e-05	0.000184	CcSEcCtD
Acetaminophen—Pruritus—Doxorubicin—kidney cancer	2.5e-05	0.000181	CcSEcCtD
Acetaminophen—Diarrhoea—Doxorubicin—kidney cancer	2.41e-05	0.000175	CcSEcCtD
Acetaminophen—Dizziness—Doxorubicin—kidney cancer	2.33e-05	0.000169	CcSEcCtD
Acetaminophen—Vomiting—Doxorubicin—kidney cancer	2.24e-05	0.000163	CcSEcCtD
Acetaminophen—Rash—Doxorubicin—kidney cancer	2.22e-05	0.000162	CcSEcCtD
Acetaminophen—Dermatitis—Doxorubicin—kidney cancer	2.22e-05	0.000161	CcSEcCtD
Acetaminophen—Headache—Doxorubicin—kidney cancer	2.21e-05	0.00016	CcSEcCtD
Acetaminophen—Nausea—Doxorubicin—kidney cancer	2.1e-05	0.000152	CcSEcCtD
Acetaminophen—CYP1A2—Metabolism—ALDH1A1—kidney cancer	5.4e-06	6.22e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—CRABP1—kidney cancer	5.38e-06	6.2e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—SCARB1—kidney cancer	5.31e-06	6.12e-05	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—GSTT1—kidney cancer	5.28e-06	6.08e-05	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—ACHE—kidney cancer	5.28e-06	6.08e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—PPAT—kidney cancer	5.27e-06	6.07e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—GLIPR1—kidney cancer	5.27e-06	6.07e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—PTGS1—kidney cancer	5.26e-06	6.05e-05	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—CYP1A1—kidney cancer	5.23e-06	6.03e-05	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—CYP1A1—kidney cancer	5.23e-06	6.03e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—CA9—kidney cancer	5.2e-06	5.99e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—PGK1—kidney cancer	5.18e-06	5.96e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—SLC5A3—kidney cancer	5.18e-06	5.96e-05	CbGpPWpGaD
Acetaminophen—UGT2B15—Metabolism—PIK3CA—kidney cancer	5.17e-06	5.96e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—PSMD7—kidney cancer	5.15e-06	5.94e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—CA9—kidney cancer	5.15e-06	5.93e-05	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—MAPK3—kidney cancer	5.14e-06	5.92e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	5.14e-06	5.92e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—LDHB—kidney cancer	5.08e-06	5.85e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	5.04e-06	5.8e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	5.03e-06	5.8e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—ITPR2—kidney cancer	5e-06	5.76e-05	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—MYC—kidney cancer	5e-06	5.76e-05	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—SCARB1—kidney cancer	5e-06	5.76e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—ACHE—kidney cancer	4.98e-06	5.73e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—GSTT1—kidney cancer	4.98e-06	5.73e-05	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	4.97e-06	5.72e-05	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—PTGS1—kidney cancer	4.95e-06	5.7e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—APRT—kidney cancer	4.9e-06	5.65e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—FH—kidney cancer	4.9e-06	5.65e-05	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—GSTP1—kidney cancer	4.9e-06	5.64e-05	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—MAPK1—kidney cancer	4.89e-06	5.64e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—BCHE—kidney cancer	4.89e-06	5.63e-05	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—PSMD7—kidney cancer	4.85e-06	5.59e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—SLC5A5—kidney cancer	4.83e-06	5.56e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	4.72e-06	5.44e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—SCARB1—kidney cancer	4.71e-06	5.43e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—CRABP1—kidney cancer	4.69e-06	5.4e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—PTGS1—kidney cancer	4.66e-06	5.37e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—SLC2A1—kidney cancer	4.66e-06	5.37e-05	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—ABCB1—kidney cancer	4.64e-06	5.34e-05	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—GSTP1—kidney cancer	4.63e-06	5.33e-05	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—KRAS—kidney cancer	4.62e-06	5.32e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism of lipids and lipoproteins—POMC—kidney cancer	4.61e-06	5.31e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—GPC3—kidney cancer	4.61e-06	5.31e-05	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—BCHE—kidney cancer	4.6e-06	5.3e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—PSMD7—kidney cancer	4.57e-06	5.27e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	4.57e-06	5.26e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—ACHE—kidney cancer	4.56e-06	5.26e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—GSTT1—kidney cancer	4.56e-06	5.26e-05	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—SLC5A5—kidney cancer	4.54e-06	5.23e-05	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—GSTM1—kidney cancer	4.5e-06	5.18e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—CDKN2B—kidney cancer	4.5e-06	5.18e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—CA2—kidney cancer	4.48e-06	5.16e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—CRABP1—kidney cancer	4.42e-06	5.09e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—CA9—kidney cancer	4.4e-06	5.07e-05	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—SLC2A1—kidney cancer	4.39e-06	5.05e-05	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—ABCB1—kidney cancer	4.38e-06	5.05e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—CRABP1—kidney cancer	4.38e-06	5.05e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—ALAD—kidney cancer	4.37e-06	5.03e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—ITPR2—kidney cancer	4.36e-06	5.02e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—BCHE—kidney cancer	4.34e-06	4.99e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—SCARB1—kidney cancer	4.32e-06	4.98e-05	CbGpPWpGaD
Acetaminophen—UGT1A6—Metabolism—PIK3CA—kidney cancer	4.32e-06	4.97e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	4.3e-06	4.96e-05	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	4.3e-06	4.95e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—SLC5A5—kidney cancer	4.28e-06	4.93e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—PTGS1—kidney cancer	4.28e-06	4.93e-05	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—CYP1A1—kidney cancer	4.27e-06	4.91e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—ST3GAL2—kidney cancer	4.27e-06	4.91e-05	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—GSTM1—kidney cancer	4.26e-06	4.9e-05	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—PIK3CA—kidney cancer	4.25e-06	4.89e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—PSMD7—kidney cancer	4.19e-06	4.83e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—ALDH1A1—kidney cancer	4.17e-06	4.8e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—SLC2A1—kidney cancer	4.14e-06	4.77e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—ITPR2—kidney cancer	4.11e-06	4.73e-05	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—TP53—kidney cancer	4.11e-06	4.73e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—ITPR2—kidney cancer	4.07e-06	4.69e-05	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—CYP1A1—kidney cancer	4.03e-06	4.65e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	4.01e-06	4.62e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—PGK1—kidney cancer	4e-06	4.6e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—SLC5A3—kidney cancer	4e-06	4.6e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—GSTT1—kidney cancer	3.98e-06	4.58e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—ACHE—kidney cancer	3.98e-06	4.58e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—BCHE—kidney cancer	3.98e-06	4.58e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.94e-06	4.54e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—SLC5A5—kidney cancer	3.93e-06	4.52e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—LDHB—kidney cancer	3.92e-06	4.51e-05	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—POMC—kidney cancer	3.9e-06	4.49e-05	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—POMC—kidney cancer	3.9e-06	4.49e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—GSTP1—kidney cancer	3.89e-06	4.48e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—SLC2A1—kidney cancer	3.79e-06	4.37e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—SCARB1—kidney cancer	3.76e-06	4.33e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	3.75e-06	4.32e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—ACHE—kidney cancer	3.75e-06	4.32e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—GSTT1—kidney cancer	3.75e-06	4.32e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—CRABP1—kidney cancer	3.74e-06	4.31e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—PTGS1—kidney cancer	3.73e-06	4.29e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—GSTT1—kidney cancer	3.71e-06	4.28e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—ACHE—kidney cancer	3.71e-06	4.28e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—ABCB1—kidney cancer	3.68e-06	4.24e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	3.68e-06	4.24e-05	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—GSTP1—kidney cancer	3.66e-06	4.22e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—PSMD7—kidney cancer	3.65e-06	4.21e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—HIF1A—kidney cancer	3.6e-06	4.14e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—TSC2—kidney cancer	3.59e-06	4.13e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—GSTM1—kidney cancer	3.57e-06	4.12e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—SCARB1—kidney cancer	3.55e-06	4.09e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—SCARB1—kidney cancer	3.52e-06	4.05e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—PTGS1—kidney cancer	3.51e-06	4.04e-05	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.51e-06	4.04e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.5e-06	4.03e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—ITPR2—kidney cancer	3.48e-06	4.01e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—PTGS1—kidney cancer	3.48e-06	4.01e-05	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—ABCB1—kidney cancer	3.46e-06	3.99e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—BCHE—kidney cancer	3.46e-06	3.99e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—GSTP1—kidney cancer	3.45e-06	3.97e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—PSMD7—kidney cancer	3.44e-06	3.97e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—SLC5A5—kidney cancer	3.42e-06	3.94e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—PSMD7—kidney cancer	3.41e-06	3.93e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—CA9—kidney cancer	3.4e-06	3.91e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—CYP1A1—kidney cancer	3.39e-06	3.9e-05	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—GSTM1—kidney cancer	3.36e-06	3.87e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—SLC2A1—kidney cancer	3.3e-06	3.81e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—ABCB1—kidney cancer	3.27e-06	3.76e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—BCHE—kidney cancer	3.26e-06	3.76e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—BCHE—kidney cancer	3.24e-06	3.73e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—SLC5A5—kidney cancer	3.22e-06	3.71e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.21e-06	3.7e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	3.21e-06	3.7e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—SLC5A5—kidney cancer	3.2e-06	3.68e-05	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—CYP1A1—kidney cancer	3.19e-06	3.67e-05	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—POMC—kidney cancer	3.18e-06	3.66e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—ACHE—kidney cancer	3.17e-06	3.66e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—GSTT1—kidney cancer	3.17e-06	3.66e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—GSTM1—kidney cancer	3.17e-06	3.65e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—APC—kidney cancer	3.17e-06	3.65e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—KIT—kidney cancer	3.17e-06	3.65e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—GSTP1—kidney cancer	3.16e-06	3.64e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	3.15e-06	3.63e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—SLC2A1—kidney cancer	3.11e-06	3.59e-05	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—PTGS2—kidney cancer	3.11e-06	3.58e-05	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—PTGS2—kidney cancer	3.11e-06	3.58e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—SLC2A1—kidney cancer	3.09e-06	3.56e-05	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—POMC—kidney cancer	3.01e-06	3.46e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—SCARB1—kidney cancer	3e-06	3.46e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.99e-06	3.45e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—ABCB1—kidney cancer	2.99e-06	3.45e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—BRAF—kidney cancer	2.98e-06	3.43e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—PTGS1—kidney cancer	2.97e-06	3.43e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—PSMD7—kidney cancer	2.92e-06	3.36e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—GSTM1—kidney cancer	2.91e-06	3.35e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—CRABP1—kidney cancer	2.89e-06	3.33e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.78e-06	3.2e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—BCHE—kidney cancer	2.77e-06	3.18e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—GSTP1—kidney cancer	2.76e-06	3.17e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—CYP1A1—kidney cancer	2.76e-06	3.17e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—SLC5A5—kidney cancer	2.73e-06	3.15e-05	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—PTEN—kidney cancer	2.71e-06	3.13e-05	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—PTEN—kidney cancer	2.71e-06	3.13e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—ITPR2—kidney cancer	2.69e-06	3.09e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—SLC2A1—kidney cancer	2.64e-06	3.04e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.61e-06	3.01e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—GSTP1—kidney cancer	2.6e-06	2.99e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—GSTP1—kidney cancer	2.57e-06	2.97e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.56e-06	2.95e-05	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—PTGS2—kidney cancer	2.54e-06	2.92e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—GSTM1—kidney cancer	2.53e-06	2.92e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—POMC—kidney cancer	2.53e-06	2.91e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—RAF1—kidney cancer	2.49e-06	2.86e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.47e-06	2.84e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—ERBB2—kidney cancer	2.46e-06	2.83e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—ABCB1—kidney cancer	2.46e-06	2.83e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—GSTT1—kidney cancer	2.45e-06	2.82e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—ACHE—kidney cancer	2.45e-06	2.82e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—ABCB1—kidney cancer	2.44e-06	2.81e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—MTOR—kidney cancer	2.43e-06	2.8e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—CD4—kidney cancer	2.42e-06	2.79e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—CYP1A1—kidney cancer	2.4e-06	2.77e-05	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—PTGS2—kidney cancer	2.4e-06	2.76e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—GSTM1—kidney cancer	2.39e-06	2.75e-05	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—POMC—kidney cancer	2.38e-06	2.74e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—GSTM1—kidney cancer	2.37e-06	2.73e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—SCARB1—kidney cancer	2.32e-06	2.67e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—PTGS1—kidney cancer	2.3e-06	2.64e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—CDKN1B—kidney cancer	2.28e-06	2.62e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.26e-06	2.61e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—CYP1A1—kidney cancer	2.26e-06	2.61e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—PSMD7—kidney cancer	2.25e-06	2.59e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—CYP1A1—kidney cancer	2.24e-06	2.58e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—POMC—kidney cancer	2.24e-06	2.58e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.23e-06	2.57e-05	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—PTEN—kidney cancer	2.21e-06	2.55e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—GSTP1—kidney cancer	2.2e-06	2.53e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—CTNNB1—kidney cancer	2.15e-06	2.48e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—BCHE—kidney cancer	2.13e-06	2.46e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—SLC5A5—kidney cancer	2.11e-06	2.43e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—PTEN—kidney cancer	2.1e-06	2.42e-05	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—PTEN—kidney cancer	2.09e-06	2.41e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—ABCB1—kidney cancer	2.08e-06	2.4e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—POMC—kidney cancer	2.05e-06	2.37e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—SLC2A1—kidney cancer	2.04e-06	2.34e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—GSTM1—kidney cancer	2.02e-06	2.33e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—CYP1A1—kidney cancer	1.92e-06	2.21e-05	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—PIK3CA—kidney cancer	1.91e-06	2.21e-05	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—PIK3CA—kidney cancer	1.91e-06	2.21e-05	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—PTGS2—kidney cancer	1.9e-06	2.18e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.84e-06	2.12e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—MAPK3—kidney cancer	1.79e-06	2.06e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—POMC—kidney cancer	1.79e-06	2.06e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—PTGS2—kidney cancer	1.79e-06	2.06e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—PTEN—kidney cancer	1.76e-06	2.02e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—MYC—kidney cancer	1.74e-06	2.01e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—MAPK1—kidney cancer	1.71e-06	1.96e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—GSTP1—kidney cancer	1.7e-06	1.96e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—POMC—kidney cancer	1.69e-06	1.94e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—POMC—kidney cancer	1.67e-06	1.93e-05	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—PTEN—kidney cancer	1.65e-06	1.9e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—PTGS2—kidney cancer	1.64e-06	1.89e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—KRAS—kidney cancer	1.61e-06	1.86e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—ABCB1—kidney cancer	1.61e-06	1.85e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.57e-06	1.81e-05	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—PIK3CA—kidney cancer	1.56e-06	1.8e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—GSTM1—kidney cancer	1.56e-06	1.8e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—PTEN—kidney cancer	1.56e-06	1.8e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—PIK3CA—kidney cancer	1.48e-06	1.7e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—CYP1A1—kidney cancer	1.48e-06	1.7e-05	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—PIK3CA—kidney cancer	1.48e-06	1.7e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—PTEN—kidney cancer	1.43e-06	1.65e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—POMC—kidney cancer	1.43e-06	1.65e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—PTGS2—kidney cancer	1.43e-06	1.64e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—PTGS2—kidney cancer	1.35e-06	1.55e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—PTGS2—kidney cancer	1.33e-06	1.54e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—PTEN—kidney cancer	1.25e-06	1.43e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—PIK3CA—kidney cancer	1.24e-06	1.43e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—PTEN—kidney cancer	1.17e-06	1.35e-05	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—PIK3CA—kidney cancer	1.17e-06	1.34e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—PTEN—kidney cancer	1.16e-06	1.34e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—PTGS2—kidney cancer	1.14e-06	1.31e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—POMC—kidney cancer	1.1e-06	1.27e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—PIK3CA—kidney cancer	1.1e-06	1.27e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—PIK3CA—kidney cancer	1.01e-06	1.16e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—PTEN—kidney cancer	9.94e-07	1.14e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—PTGS2—kidney cancer	8.8e-07	1.01e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—PIK3CA—kidney cancer	8.78e-07	1.01e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—PIK3CA—kidney cancer	8.28e-07	9.53e-06	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—PIK3CA—kidney cancer	8.21e-07	9.45e-06	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—PTEN—kidney cancer	7.67e-07	8.84e-06	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—PIK3CA—kidney cancer	7.01e-07	8.08e-06	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—PIK3CA—kidney cancer	5.41e-07	6.23e-06	CbGpPWpGaD
